Ophthalmic Drugs Market Size, Global Overview, Growth Values and Forecast to 2023


Market Overview:
Increased level of research in the market is expected to motivate the development of ophthalmic drugs. The expansion of the pharmaceutical sector is expected to motivate the market at an incremental rate in the coming years. Moreover, increased government backing is expected to encourage the progress of the ophthalmic drug market in the approaching years.
The global Ophthalmic Drugs Market Size is expected to exhibit a strong 6% CAGR over the forecast period, according to the latest research report from Market Research Future (MRFR).
Reports that review the pharmaceutical industry have been offered by Market Research Future, which generates reports on industry verticals that evaluate the market development and opportunities.

Competitive Analysis:
·         Valeant Pharmaceuticals International In
·         Teva Pharmaceutical Industries Ltd
·         Sun Pharmaceutical Industries Ltd
·         Shire plc
·         Santen Pharmaceutical Co
·         Regeneron Pharmaceuticals Inc
·         Pfizer Inc
·         Merck & Co
·         Genentech Inc
·         Bausch & Lomb Inc
·         Allergan plc
·         Actavis Generics

Segmentation:
·         The global ophthalmic drugs market is segmented on the basis of indication, drug class, type of dosage, product, and distribution channel.
·         On the basis of indication, the market is classified as glaucoma, retinal disorders, inflammation/infection, dry eye, allergies, uveitis, and others.
·         On the basis of drug class, the market is classified as antiallergy, anti-VEGF agents, anti-inflammatory, antiglaucoma, and others. The anti-inflammatory segment is further segmented into nonsteroidal drugs and steroidal drugs.
·         On the basis of type of dosage, the market is classified as eye drops, eye solutions, ointments, capsules and tablets, and gels.
·         On the basis of the product, the market is classified as prescription drugs and OTC drugs.
·         On the basis of the distribution channel, the market is classified as hospital pharmacies, online pharmacies, drug stores, and others.

Regional Analysis:
The Americas dominates the global ophthalmic drugs market and is likely to remain the leading regional market over the forecast period due to the rising prevalence of ophthalmic conditions and the high healthcare expenditure in the region. Glaucoma accounts for up to 10 million visits to the physician in the U.S., leading to considerable expenses and demand for drugs. More than 120,000 in the U.S. are blind because of glaucoma. These numbers are highly good news for the ophthalmic drugs market in the Americas. The growing patient population suffering from ophthalmic diseases is likely to drive the Americas market for ophthalmic drugs over the forecast period. North America is likely to remain the leading revenue generator in the global ophthalmic drugs market over the forecast period.
Europe is likely to hold on to the second place in the global ophthalmic drugs market over the forecast period due to a similar set of reasons. The growing patient population in Europe for ophthalmic diseases

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more